Our results indicate that the GLI1-mediated regulation of ABCG2 is an important mechanism responsible for maintenance of the residual cancer cells (or putative cancer stem cells) in gastric cancer following treatment with CDDP, a major chemotherapeutical drug. This evidence concerns the gene ABCG2 and cancer.